Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 1
2011 3
2012 2
2013 3
2014 1
2015 1
2016 6
2017 5
2018 7
2019 7
2020 13
2021 13
2022 18
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Regenerative medicine: postnatal approaches.
Tam PKH, Wong KKY, Atala A, Giobbe GG, Booth C, Gruber PJ, Monone M, Rafii S, Rando TA, Vacanti J, Comer CD, Elvassore N, Grikscheit T, de Coppi P. Tam PKH, et al. Among authors: booth c. Lancet Child Adolesc Health. 2022 Sep;6(9):654-666. doi: 10.1016/S2352-4642(22)00193-6. Lancet Child Adolesc Health. 2022. PMID: 35963270 Review.
Lentiviral gene therapy for X-linked chronic granulomatous disease.
Kohn DB, Booth C, Kang EM, Pai SY, Shaw KL, Santilli G, Armant M, Buckland KF, Choi U, De Ravin SS, Dorsey MJ, Kuo CY, Leon-Rico D, Rivat C, Izotova N, Gilmour K, Snell K, Dip JX, Darwish J, Morris EC, Terrazas D, Wang LD, Bauser CA, Paprotka T, Kuhns DB, Gregg J, Raymond HE, Everett JK, Honnet G, Biasco L, Newburger PE, Bushman FD, Grez M, Gaspar HB, Williams DA, Malech HL, Galy A, Thrasher AJ; Net4CGD consortium. Kohn DB, et al. Among authors: booth c. Nat Med. 2020 Feb;26(2):200-206. doi: 10.1038/s41591-019-0735-5. Epub 2020 Jan 27. Nat Med. 2020. PMID: 31988463 Free PMC article. Clinical Trial.
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Kohn DB, Booth C, Shaw KL, Xu-Bayford J, Garabedian E, Trevisan V, Carbonaro-Sarracino DA, Soni K, Terrazas D, Snell K, Ikeda A, Leon-Rico D, Moore TB, Buckland KF, Shah AJ, Gilmour KC, De Oliveira S, Rivat C, Crooks GM, Izotova N, Tse J, Adams S, Shupien S, Ricketts H, Davila A, Uzowuru C, Icreverzi A, Barman P, Campo Fernandez B, Hollis RP, Coronel M, Yu A, Chun KM, Casas CE, Zhang R, Arduini S, Lynn F, Kudari M, Spezzi A, Zahn M, Heimke R, Labik I, Parrott R, Buckley RH, Reeves L, Cornetta K, Sokolic R, Hershfield M, Schmidt M, Candotti F, Malech HL, Thrasher AJ, Gaspar HB. Kohn DB, et al. Among authors: booth c. N Engl J Med. 2021 May 27;384(21):2002-2013. doi: 10.1056/NEJMoa2027675. Epub 2021 May 11. N Engl J Med. 2021. PMID: 33974366 Free PMC article. Clinical Trial.
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A, Waters E, Rowshanravan B, Hinze C, Williams C, Janman D, Fox TA, Booth C, Pesenacker AM, Halliday N, Soskic B, Kaur S, Qureshi OS, Morris EC, Ikemizu S, Paluch C, Huo J, Davis SJ, Boucrot E, Walker LSK, Sansom DM. Kennedy A, et al. Among authors: booth c. Nat Immunol. 2022 Sep;23(9):1365-1378. doi: 10.1038/s41590-022-01289-w. Epub 2022 Aug 23. Nat Immunol. 2022. PMID: 35999394 Free PMC article.
Gene Therapy for Primary Immunodeficiency.
Houghton BC, Booth C. Houghton BC, et al. Among authors: booth c. Hemasphere. 2020 Dec 29;5(1):e509. doi: 10.1097/HS9.0000000000000509. eCollection 2021 Jan. Hemasphere. 2020. PMID: 33403354 Free PMC article. Review.
Gene Therapy for Inborn Errors of Immunity.
Arlabosse T, Booth C, Candotti F. Arlabosse T, et al. Among authors: booth c. J Allergy Clin Immunol Pract. 2023 Jun;11(6):1592-1601. doi: 10.1016/j.jaip.2023.04.001. Epub 2023 Apr 20. J Allergy Clin Immunol Pract. 2023. PMID: 37084938 Review.
Gene therapy for primary immunodeficiencies.
Fox TA, Booth C. Fox TA, et al. Among authors: booth c. Br J Haematol. 2021 Jun;193(6):1044-1059. doi: 10.1111/bjh.17269. Epub 2020 Dec 18. Br J Haematol. 2021. PMID: 33336808 Free article. Review.
Gene therapy for primary immunodeficiency.
Booth C, Romano R, Roncarolo MG, Thrasher AJ. Booth C, et al. Hum Mol Genet. 2019 Oct 1;28(R1):R15-R23. doi: 10.1093/hmg/ddz170. Hum Mol Genet. 2019. PMID: 31297531 Review.
Gene therapy for primary immunodeficiencies: up-to-date.
Chetty K, Booth C. Chetty K, et al. Among authors: booth c. Expert Opin Biol Ther. 2021 Apr;21(4):529-538. doi: 10.1080/14712598.2021.1837108. Epub 2020 Oct 29. Expert Opin Biol Ther. 2021. PMID: 33078662 Review.
Therapeutic gene editing of T cells to correct CTLA-4 insufficiency.
Fox TA, Houghton BC, Petersone L, Waters E, Edner NM, McKenna A, Preham O, Hinze C, Williams C, de Albuquerque AS, Kennedy A, Pesenacker AM, Genovese P, Walker LSK, Burns SO, Sansom DM, Booth C, Morris EC. Fox TA, et al. Among authors: booth c. Sci Transl Med. 2022 Oct 26;14(668):eabn5811. doi: 10.1126/scitranslmed.abn5811. Epub 2022 Oct 26. Sci Transl Med. 2022. PMID: 36288278
81 results